Amphotericin
Amphotericin has been studied in 1 paper since 2022: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, Jan 1, 2022: “CROI 2022: neurologic complications of HIV-1, SARS-CoV-2, and other pathogens”.
See all 7 papers on amphotericin
Latest
2 papers in 12 monthsTopics in Antiviral Medicine
CROI 2022: neurologic complications of HIV-1, SARS-CoV-2, and other pathogens
ReviewMechanisms
Future Microbiology
Repurposing statins as potential antifungal agents for Candida albicans: in-vitro and in-silico approach
Experiments in cellsStatins
Exploration of Drug Science
Janus-faced role of anti-infective drugs: a revisit through the lens of vascular ageing
Systematic reviewInterventions
Naunyn-Schmiedeberg's Archives of Pharmacology
Intravitreal ranibizumab injection is associated with an increased risk of chronic kidney disease: a population-based study in Taiwan
Cohort study of 48,248 peopleChronic kidney disease
Scientific Reports
Gene Duplication Associated with Increased Fluconazole Tolerance in Candida auris cells of Advanced Generational Age
Experiments in model organismsMechanisms
Aging Clinical and Experimental Research
Colistin nephrotoxicity in the ICU: Is it different in the geriatric patients?
Study in peoplePopulations